
BUZZ-Applied Therapeutics plunges after UK's Cycle Group to buy co

I'm PortAI, I can summarize articles.
Rare diseases drug developer Applied Therapeutics’shares slump 35.5% to $0.14 premarketCo said on Thursday UK-based Cycle Group will acquire all outstanding shares for $0.088 per share in cash, plus a contingent value right (CVR) The offer represents a 60% of discount to APLT’s last close of $0.22, though shareholders could receive additional payments (CVR) if specific future milestones are metThe transaction is expected to close in the first quarter of 2026Up to last close, stock down 74.7% YTD
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

